Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OrthoLogic unapproved bone stimulators cited in warning letter are custom devices, firm claims.

This article was originally published in The Gray Sheet

Executive Summary

ORTHOLOGIC BONE STIMULATORS CITED IN WARNING LETTER ARE CUSTOM DEVICES and therefore do not require FDA approval via a premarket approval application supplement, the company has told FDA. In a May 31 warning letter, FDA charged that OrthoLogic "reconfigured" OrthoLogic 1000 bone stimulators for unapproved indications "without prior approval from the agency." OrthoLogic maintains that the products fit the definition of a custom device because they are manufactured in response to physician requests and are not generally available, kept in inventory or promoted for distribution. Custom devices are exempt from premarket approval requirements.
UsernamePublicRestriction

Register

MT006252

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel